NPCE
Neuropace, Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Neuropace (NPCE) Stock: Buy, Sell, or Hold?
$12.52
-0.17 (-1.34%)
âŧ
5d:
-6.15%
30d:
-1.26%
90d:
-13.71%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
TODAY
Protect NPCE Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
46/100
Position
SLIGHTLY LOW
30-Day Fair Range
$12.47 â $13.11
Position: SLIGHTLY LOW
Forward P/E & Valuation
-57.6x
Next 12M consensus est.
Wall Street Target
$20.00
+59.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$12.00 / $13.94
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: NPCE is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When NPCE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NPCE is currently trading at $12.52, which is considered slightly low relative to its 30-day fair value range of $12.47 to $13.11.
Technical Outlook: Technically, NPCE is in a strong downtrend. Immediate support is located at $12.00, while resistance sits at $13.94.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.00 (+59.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NPCE is in a strong downtrend. Immediate support is located at $12.00, while resistance sits at $13.94.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.00 (+59.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$12.47 -
$13.11
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$12.47 -
$13.11
Current vs Trading Range
SLIGHTLY LOW
Support Level
$12.00
Resistance Level
$13.94
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding NPCE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (51/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 59.7% below Wall St target ($20.00)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-57.56
Wall Street Target
$20.00
(+59.7%)
Revenue Growth (YoY)
17.1%
Profit Margin
-17.9%
Share NPCE Analysis
Share this live NPCE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NPCE)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jun 24, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message indicates a long-term investment in $NPCE.
Key Retail Themes:
Long-term investment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:17 PM ET
Data refreshes hourly during market hours. Next update: 6:17 PM
Data refreshes hourly during market hours. Next update: 6:17 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NPCE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 38 SELL |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 38 SELL |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 39 SELL |
Advanced NPCE Option Strategies
Professional options setups generated by AI based on today's NPCE price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NPCE Research Pages
